DIN 02558351 — VANFLYTA 17.7 MG
VANFLYTA is a tablet of Quizartinib marketed by DAIICHI SANKYO PHARMA CANADA LIMITED. The full Quizartinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02558351
- Brand name
- VANFLYTA
- Active ingredient
- Quizartinib
- Strength
- 17.7 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- DAIICHI SANKYO PHARMA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- FLT3 kinase inhibitor (antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Quizartinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02558378 | VANFLYTA | 26.5 MG | TABLET | DAIICHI SANKYO PHARMA CANADA LIMITED | MARKETED |